Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Short-term Investments: 2010-2025

Historic Short-term Investments for BIO-TECHNE (TECH) over the last 16 years, with Jun 2025 value amounting to $2.8 million.

  • BIO-TECHNE's Short-term Investments fell 71.03% to $2.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.8 million, marking a year-over-year decrease of 71.03%. This contributed to the annual value of $2.8 million for FY2025, which is 71.03% down from last year.
  • According to the latest figures from FY2025, BIO-TECHNE's Short-term Investments is $2.8 million, which was down 71.03% from $9.8 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Short-term Investments ranged from a high of $74.5 million in FY2022 and a low of $2.8 million during FY2025.
  • In the last 3 years, BIO-TECHNE's Short-term Investments had a median value of $9.8 million in 2024 and averaged $12.1 million.
  • Per our database at Business Quant, BIO-TECHNE's Short-term Investments plummeted by 73.88% in 2021 and then surged by 129.37% in 2022.
  • BIO-TECHNE's Short-term Investments (Yearly) stood at $32.5 million in 2021, then soared by 129.37% to $74.5 million in 2022, then crashed by 68.12% to $23.7 million in 2023, then tumbled by 58.66% to $9.8 million in 2024, then crashed by 71.03% to $2.8 million in 2025.